128 related articles for article (PubMed ID: 12270857)
21. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular Disease Risk Associated With the Long-term Use of Depot Medroxyprogesterone Acetate.
Dilshad H; Yousuf RI; Shoaib MH; Jamil S; Khatoon H
Am J Med Sci; 2016 Nov; 352(5):487-492. PubMed ID: 27865296
[TBL] [Abstract][Full Text] [Related]
23. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
24. Acute hypoxaemia and vascular function in healthy humans.
Lewis NCS; Bain AR; Wildfong KW; Green DJ; Ainslie PN
Exp Physiol; 2017 Dec; 102(12):1635-1646. PubMed ID: 28901662
[TBL] [Abstract][Full Text] [Related]
25. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
26. Oestradiol improves arterial endothelial function in healthy men receiving testosterone.
Sader MA; McCredie RJ; Griffiths KA; Wishart SM; Handelsman DJ; Celermajer DS
Clin Endocrinol (Oxf); 2001 Feb; 54(2):175-81. PubMed ID: 11207631
[TBL] [Abstract][Full Text] [Related]
27. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception].
Zhu M; Lei Z; Yang D
Zhonghua Fu Chan Ke Za Zhi; 1999 Oct; 34(10):621-3. PubMed ID: 11477805
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
31. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
32. Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1630-7. PubMed ID: 18281378
[TBL] [Abstract][Full Text] [Related]
33. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
34. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction?
Guthikonda S; Sinkey CA; Haynes WG
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1172-6. PubMed ID: 17303783
[TBL] [Abstract][Full Text] [Related]
35. The impact of short-term depot-medroxyprogesterone acetate treatment on resting metabolic rate.
Steward RG; Bateman LA; Slentz C; Stanczyk FZ; Price TM
Contraception; 2016 Apr; 93(4):317-322. PubMed ID: 26772904
[TBL] [Abstract][Full Text] [Related]
36. A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users.
Merki-Feld GS; Neff M; Keller PJ
Contraception; 2003 Feb; 67(2):79-86. PubMed ID: 12586317
[TBL] [Abstract][Full Text] [Related]
37. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
[TBL] [Abstract][Full Text] [Related]
38. Long-acting injectable contraception with depot medroxyprogesterone acetate.
Kaunitz AM
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate complexity and proportion of serum FSH isoforms reflect pituitary-ovarian activity in perimenopausal women and depot medroxyprogesterone acetate users.
Loreti N; Ambao V; Juliato CT; Machado C; Bahamondes L; Campo S
Clin Endocrinol (Oxf); 2009 Oct; 71(4):558-65. PubMed ID: 19250269
[TBL] [Abstract][Full Text] [Related]
40. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Kaunitz AM
Circulation; 2003 Mar; 107(9):e67-8; author reply e67-8. PubMed ID: 12628963
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
